These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

925 related articles for article (PubMed ID: 30340496)

  • 1. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
    Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
    Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial.
    Kort DH; Lobo RA
    Am J Obstet Gynecol; 2014 Nov; 211(5):487.e1-6. PubMed ID: 24813595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome.
    Seow KM; Ting CH; Huang SW; Ho LT; Juan CC
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroepiandrosterone with a high-fat diet treatment at inducing polycystic ovary syndrome in rat model.
    He Y; Li X; Li Y; Kuai D; Zhang H; Wang Y; Tian W
    Steroids; 2024 Jun; 206():109424. PubMed ID: 38642598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome.
    Lai H; Jia X; Yu Q; Zhang C; Qiao J; Guan Y; Kang J
    Biol Reprod; 2014 Nov; 91(5):127. PubMed ID: 25100714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes.
    Wu H; Zhao B; Yao Q; Kang J
    J Ovarian Res; 2023 Oct; 16(1):207. PubMed ID: 37880784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-androgenic effect of quercetin on hyperandrogenism and ovarian dysfunction induced in a dehydroepiandrosterone rat model of polycystic ovary syndrome.
    Mahmoud AA; Elfiky AM; Abo-Zeid FS
    Steroids; 2022 Jan; 177():108936. PubMed ID: 34752810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
    Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: A randomized double-blind placebo controlled clinical trial.
    Hajimonfarednejad M; Nimrouzi M; Heydari M; Zarshenas MM; Raee MJ; Jahromi BN
    Phytother Res; 2018 Feb; 32(2):276-283. PubMed ID: 29250843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Electroacupuncture on Reproductive Disorders and Insulin Resistance in a Murine Polycystic Ovary Syndrome Model.
    Ji C; Xu W; Zhang Z; Cui S; Yi W
    Evid Based Complement Alternat Med; 2021; 2021():9968463. PubMed ID: 34987599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIF May Participate in Pathogenesis of Polycystic Ovary Syndrome in Rats through MAPK Signalling Pathway.
    Zhou DN; Li SJ; Ding JL; Yin TL; Yang J; Ye H
    Curr Med Sci; 2018 Oct; 38(5):853-860. PubMed ID: 30341520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interlukin-22 improves ovarian function in polycystic ovary syndrome independent of metabolic regulation: a mouse-based experimental study.
    Chen W; Liao B; Yun C; Zhao M; Pang Y
    J Ovarian Res; 2024 May; 17(1):100. PubMed ID: 38734641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isorhamnetin inhibits inflammatory response to alleviate DHEA-induced polycystic ovary syndrome in rats.
    Yu F; Xue Y; Zhao Y; Zhang L; He X; Liu Z
    Gynecol Endocrinol; 2023 Dec; 39(1):2183045. PubMed ID: 36842967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ameliorative effects of marjoram in dehydroepiandrosterone induced polycystic ovary syndrome in rats.
    Rababa'h AM; Matani BR; Ababneh MA
    Life Sci; 2020 Nov; 261():118353. PubMed ID: 32877649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats.
    Wu LM; Wang YX; Zhan Y; Liu AH; Wang YX; Shen HF; Wang YF; Wang LY; Tao ZB; Wang YQ
    Peptides; 2021 Nov; 145():170624. PubMed ID: 34375684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats.
    Zhang X; Zhang C; Shen S; Xia Yj; Yi L; Gao Q; Wang Y
    Hum Reprod; 2013 Nov; 28(11):3074-85. PubMed ID: 23980058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Hawthorn Leaf Flavonoids in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome in Rats.
    Shi Y; Kong X; Yin H; Zhang W; Wang W
    Pathobiology; 2019; 86(2-3):102-110. PubMed ID: 30404093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like factor 3 -- a new hormone related to polycystic ovary syndrome?
    Szydlarska D; Grzesiuk W; Trybuch A; Kondracka A; Kowalik I; Bar-Andziak E
    Endokrynol Pol; 2012; 63(5):356-61. PubMed ID: 23115068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway.
    Zhao H; Zhou D; Chen Y; Liu D; Chu S; Zhang S
    Daru; 2017 Oct; 25(1):21. PubMed ID: 29020999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.